Insmed Inc Stock Investor Sentiment

INSM Stock  USD 75.16  0.72  0.95%   
About 55% of Insmed's investor base is interested to short. The analysis of the overall investor sentiment regarding Insmed Inc suggests that many traders are impartial. Insmed's investing sentiment overview a quick insight into current market opportunities from investing in Insmed Inc. Many technical investors use Insmed Inc stock news signals to limit their universe of possible portfolio assets and to time the market correctly.

Panic Vs Confidence

45

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Insmed's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Insmed Inc.

Insmed Historical Sentiment

Although Insmed's investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Insmed, such as negative comments on social media and news outlets, may cause fear in the market and push Insmed's investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Insmed.
  

Insmed Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Insmed can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Insmed Inc Historical Investor Sentiment

Investor biases related to Insmed's public news can be used to forecast risks associated with an investment in Insmed. The trend in average sentiment can be used to explain how an investor holding Insmed can time the market purely based on public headlines and social activities around Insmed Inc. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Insmed's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Insmed and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Insmed news discussions. The higher the estimate score, the more favorable the investor's outlook on Insmed.

Insmed Maximum Pain Price across 2024-12-20 Option Contracts

Insmed's options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Insmed close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Insmed's options.
over six months ago at news.google.com         
Insmed Incorporated Receives 44.92 Consensus Price Target from Analysts - Defense World
Google News at Macroaxis
over six months ago at finance.yahoo.com         
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635
Yahoo News
over six months ago at zacks.com         
Insmed Expected to Beat Earnings Estimates Should You Buy?
zacks News
over six months ago at news.google.com         
Insmed Expected to Beat Earnings Estimates Should You Buy - Yahoo Finance
Google News at Macroaxis
over six months ago at news.google.com         
abrdn plc Buys New Shares in Insmed Incorporated - MarketBeat
Google News at Macroaxis
over six months ago at finance.yahoo.com         
Insmed to Host First-Quarter 2024 Financial Results Conference Call on Thursday, May 9, 2024
Yahoo News
over six months ago at investing.com         
Insmed shares upgraded on growth potential
Investing News at Macroaxis
over six months ago at news.google.com         
Mutual of America Capital Management LLC Sells 19396 Shares of Insmed Incorporated - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
Insmed Incorporated Shares Sold by SG Americas Securities LLC - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
Arizona State Retirement System Sells 657 Shares of Insmed Incorporated - Defense World
Google News at Macroaxis
over six months ago at finance.yahoo.com         
What Makes Insmed a Lucrative Investment?
Yahoo News
over six months ago at news.google.com         
Insmed Reports Q2 Loss, Tops Revenue Estimates - Yahoo New Zealand News
Google News at Macroaxis
over six months ago at news.google.com         
Insmed Incorporated Given Consensus Recommendation of Buy by Analysts - Defense World
Google News at Macroaxis
over six months ago at finance.yahoo.com         
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635
Yahoo News
over six months ago at cnbc.com         
Here are Wells Fargos top trades for the second quarter
cnbc News
Far too much social signal, news, headlines, and media speculation about Insmed that are available to investors today. That information is available publicly through Insmed media outlets and privately through word of mouth or via Insmed internal channels. However, regardless of the origin, that massive amount of Insmed data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Insmed news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Insmed relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Insmed's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Insmed alpha.

Insmed Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635
09/06/2024
2
Disposition of 26969 shares by Flammer Martina M.d. of Insmed at 34.03 subject to Rule 16b-3
09/13/2024
3
Disposition of 730 shares by Michael Smith of Insmed at 70.05 subject to Rule 16b-3
09/27/2024
4
New Subgroup Analyses from Landmark Phase 3 ASPEN Study of Brensocatib in Patients with Bronchiectasis Demonstrate Consistency with Positive Overall Trial Popul...
10/08/2024
5
Disposition of 11900 shares by Michael Smith of Insmed at 17.16 subject to Rule 16b-3
10/11/2024
6
Heres How Much 1000 Invested In Insmed 10 Years Ago Would Be Worth Today
10/25/2024
7
Insmed Q3 Earnings Preview What You Should Know Beyond the Headline Estimates
10/30/2024
8
Insmed Third Quarter 2024 Earnings EPS Misses Expectations
11/01/2024
9
Insmed Reliance on International Sales What Investors Need to Know
11/04/2024
10
Insmed ends sales agreement with Leerink Partners
11/19/2024
11
Insmed Price Target Raised to 83.00
11/25/2024
12
Insmed Incorporated Holdings Raised by Eventide Asset Management LLC
11/29/2024
When determining whether Insmed Inc is a strong investment it is important to analyze Insmed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Insmed's future performance. For an informed investment choice regarding Insmed Stock, refer to the following important reports:
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Insmed. If investors know Insmed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Insmed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(5.55)
Revenue Per Share
2.206
Quarterly Revenue Growth
0.182
Return On Assets
(0.26)
Return On Equity
(8.91)
The market value of Insmed Inc is measured differently than its book value, which is the value of Insmed that is recorded on the company's balance sheet. Investors also form their own opinion of Insmed's value that differs from its market value or its book value, called intrinsic value, which is Insmed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Insmed's market value can be influenced by many factors that don't directly affect Insmed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Insmed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Insmed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Insmed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.